Fight against HIV/AIDS in Africa should focus more on blood safety

NewsGuard 100/100 Score

A renewed focus on unsafe blood transfusions and used syringes is needed to combat the spread of HIV in sub-Saharan Africa, Ambassador Mark Dybul -- who serves as the U.S. global AIDS coordinator and administers the President's Emergency Plan for AIDS Relief -- said on Wednesday during a visit to Zambia, Reuters reports.

Evidence shows that sexual transmission of HIV in sub-Saharan Africa is stabilizing because of education programs, Dybul said, adding that preventing transmission through blood transfusions remains a challenge in the region because of inadequate medical facilities and high HIV prevalence.

Dybul during his four-day visit aims to evaluate HIV/AIDS programs in Zambia, where one-fifth of the country's 10 million people are HIV-positive, according to official estimates (Shacinda, Reuters, 10/18).

The U.S. has pledged $149 million in PEPFAR funding in 2006 to HIV/AIDS programs in Zambia to increase access to antiretroviral drugs, train health workers and broaden counseling and testing in rural areas.

PEPFAR has committed $570 million to Zambia for its HIV/AIDS programs, according to the AP/CBS News (Mwanwangombe, AP/CBS News, 10/18).

According to Reuters, much of the funding from the U.S. goes to the Maina Soko military hospital in the capital, Lusaka, which serves only military personnel and their families.

Dybul during his visit also urged African countries to build on programs that stress abstinence and condom use and that focus on nonsexual transmission of HIV, including preventing mother-to-child HIV transmission (Reuters, 10/18).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Breakthrough study offers hope for an effective HIV cure